Literature DB >> 33659557

Minimally Invasive Oral Surgery Induction of the FRICT-ION Chronic Neuropathic Pain Model.

Marena A Montera1, Karin N Westlund1.   

Abstract

An easily induced preclinical trigeminal neuropathic nerve injury model is described here for the study of chronic pain, the model acronym FRICT-ION (Foramen Rotundum Inflammatory Constriction Trigeminal InfraOrbital Nerve). In patients, neuropathic pain is thought to be related to vascular alignment or multiple sclerosis along this small trigeminal nerve branch (V2) innervating the maxillary teeth and middle third of the face. With no detectable outward physical signs, the FRICT-ION model is ideal for blinded studies. The acronym FRICT-ION applied relates to the persistence of the trigeminal neuropathic pain model likely due to sliding irritation with normal chewing in the mice. A step-by-step method to induce the mild chronic rodent neuropathic pain model is described here. The surgery is performed orally through a tiny surgical slit inside the cheek crease to align a chromic gut suture irritant along the nerve as it passes into the skull. The model allows testing of non-evoked subjective measures and evoked quantitative mechanical hypersensitivity (allodynia) testing with von Frey filaments through at least 10-14 weeks (100 days). Anxiety and depression behaviors develop within 3-6 weeks relevant to the affective component of chronic pain. While many pain drugs have failed based on testing performed in the acute animal models available, the more stable and easily replicated trigeminal inflammatory compression model is the better suited for understanding both mechanistic and affective components of nerve injury-induced chronic neuropathic pain states as well as the more ideal for preclinical trials of novel non-opioid pain relief therapies.
Copyright © 2020 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Anxiety; Chromic gut; Chronic pain; Infraorbital nerve; Neuralgia; Neuropathic pain; Orofacial pain

Year:  2020        PMID: 33659557      PMCID: PMC7842532          DOI: 10.21769/BioProtoc.3591

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  22 in total

1.  Dysregulated TNFα promotes cytokine proteome profile increases and bilateral orofacial hypersensitivity.

Authors:  F Ma; L Zhang; H S Oz; M Mashni; K N Westlund
Journal:  Neuroscience       Date:  2015-05-29       Impact factor: 3.590

2.  Characterization of heat-hyperalgesia in an experimental trigeminal neuropathy in rats.

Authors:  Y Imamura; H Kawamoto; O Nakanishi
Journal:  Exp Brain Res       Date:  1997-08       Impact factor: 1.972

3.  Teflon granuloma after microvascular decompression for trigeminal neuralgia.

Authors:  J Chen; S Lee; T Lui; Y Yeh; T Chen; W Tzaan
Journal:  Surg Neurol       Date:  2000-03

Review 4.  Psychological factors associated with orofacial pains.

Authors:  Charles R Carlson
Journal:  Dent Clin North Am       Date:  2007-01

5.  Combination Drug Therapy of Pioglitazone and D-cycloserine Attenuates Chronic Orofacial Neuropathic Pain and Anxiety by Improving Mitochondrial Function Following Trigeminal Nerve Injury.

Authors:  Danielle N Lyons; Liping Zhang; Jignesh D Pandya; Robert J Danaher; Fei Ma; Craig S Miller; Patrick G Sullivan; Cristian Sirbu; Karin N Westlund
Journal:  Clin J Pain       Date:  2018-02       Impact factor: 3.442

6.  A time-dependent history of mood disorders in a murine model of neuropathic pain.

Authors:  Ipek Yalcin; Yohann Bohren; Elisabeth Waltisperger; Dominique Sage-Ciocca; Jerry C Yin; Marie-José Freund-Mercier; Michel Barrot
Journal:  Biol Psychiatry       Date:  2011-09-03       Impact factor: 13.382

7.  Behavioral evidence of trigeminal neuropathic pain following chronic constriction injury to the rat's infraorbital nerve.

Authors:  B P Vos; A M Strassman; R J Maciewicz
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

9.  A craniofacial-specific monosynaptic circuit enables heightened affective pain.

Authors:  Erica Rodriguez; Katsuyasu Sakurai; Jennie Xu; Yong Chen; Koji Toda; Shengli Zhao; Bao-Xia Han; David Ryu; Henry Yin; Wolfgang Liedtke; Fan Wang
Journal:  Nat Neurosci       Date:  2017-11-13       Impact factor: 24.884

10.  Sustained relief of trigeminal neuropathic pain by a blood-brain barrier penetrable PPAR gamma agonist.

Authors:  Morgan Zhang; Min Hu; Marena A Montera; Karin N Westlund
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

View more
  3 in total

1.  Trigeminal neuropathic pain is alleviated by inhibition of Cav3.3 T-type calcium channels in mice.

Authors:  Marena Montera; Aleyah Goins; Leos Cmarko; Norbert Weiss; Karin N Westlund; Sascha R A Alles
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

2.  Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction.

Authors:  K N Westlund; M A Montera; A E Goins; S R A Alles; M Afaghpour-Becklund; R Bartel; R Durvasula; A Kunamneni
Journal:  Neurobiol Pain       Date:  2021-07-15

3.  Single-Dose P2 X4R Single-Chain Fragment Variable Antibody Permanently Reverses Chronic Pain in Male Mice.

Authors:  Karin N Westlund; Marena A Montera; Aleyah E Goins; Sascha R A Alles; Nikita Suri; Sabrina L McIlwrath; Robyn Bartel; Ravi V Durvasula; Adinarayana Kunamneni
Journal:  Int J Mol Sci       Date:  2021-12-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.